Forbes Medi-Tech




Previous. All pages. Next. Page 1. Page 2

November 13, 2008  Forbes Medi-Tech Announces Third Quarter 2008 Financial Results
October 22, 2008  Forbes Medi-Tech Receives Extension to Compliance Deadline ~NASDAQ Temporarily Suspends Enforcement of the Bid Price Requirement~
October 09, 2008  Forbes Medi-Tech Showcases Frozen Fudge Bar Containing Its Cholesterol-Lowering Reducol(tm) Ingredient at the 2008 National Frozen & Refrigerated Foods Convention
September 19, 2008  Forbes Medi-Tech Provides Update on Nasdaq Listing Status
September 18, 2008  Forbes Medi-Tech Announces Reducol(tm) Expansion in South America with New Yogurt Drink Launched in Uruguay
August 21, 2008  Forbes Medi-Tech Continues European Expansion with Product Launch in Finland ~Reducol(TM) Product Line Expanded with the Introduction of Processed Cheese Slices~
August 18, 2008  Forbes Medi-Tech Announces Sale of Pharmaceutical Assets ~Company Focuses on Building Its Revenue-Generating Nutraceutical Business~
August 12, 2008  Forbes Medi-Tech Announces Second Quarter 2008 Financial Results
June 17, 2008  Forbes Medi-Tech Achieves "Minimum Bid Price Requirement" for Continued Listing on The Nasdaq Stock Market
June 09, 2008  Forbes Medi-Tech Receives Extension to Achieve Nasdaq's "Minimum Bid Price Requirement"
May 22, 2008  Forbes Medi-Tech Restructures Board by Reducing Number of Directors from Six to Four ~Greg Anderson Appointed as Director and Joe Dunne Named as Chair~
May 15, 2008  Forbes Medi-Tech Announces Corporate Restructuring --Company To Focus Exclusively on Core Nutraceutical Business and Reduce 2008 Research and Development Expenses by Approximately $2.7 Million--
May 14, 2008  Forbes Medi-Tech Announces First Quarter 2008 Financial Results
May 12, 2008  Forbes Medi-Tech Announces Completion of $3.8 Million Non-Dilutive Funding Transaction
April 24, 2008  Forbes Medi-Tech Announces Pharmavite Contract Renewal ~Following Strong Volume Growth in 2007, the Company Looks to Further Expand Product Line with Reducol(tm)-Based Products~
April 01, 2008  Forbes Medi-Tech now Trading under former NASDAQ Trading Symbol 'FMTI'
March 31, 2008  Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2007
March 20, 2008  Forbes Medi-Tech Announces $3.8 Million Non-Dilutive Funding Transaction
March 19, 2008  Forbes Enters Into New Collaboration for Reducol(tm) in Germany, Austria and Switzerland
March 10, 2008  Italy's Fiave Launches Premium Brand Natural Products with Reducol(tm)~First Brand Name Product Launch in Europe~
March 03, 2008  Forbes Medi-Tech announces Trading of Common Shares on Post-Exchange Basis
February 26, 2008  Forbes Medi-Tech Establishes Exchange Ratio for Corporate Reorganization
February 14, 2008  Forbes Medi-Tech Issues Results from Special General Meeting
February 07, 2008  Forbes Medi-Tech Forecasts Strong Revenue Growth in 2008
January 31, 2008  ISS Recommends Forbes Medi-Tech Shareholders Vote 'FOR' the Proposed Corporate Reorganization
January 23, 2008  Forbes Medi-Tech Provides Update on Nasdaq Listing Status
January 14, 2008  Forbes Medi-Tech Files Meeting Documents For Previously Announced Plan of Arrangement

Previous. All pages. Next. Page 1. Page 2